Although the exact mechanisms underlying remain to be further clarified, our findings indicate a novel role for SFRP5 as a negative regulator in MI and support its potential role in the treatment of T2DM complicate with MI. The gene discussed is SFRP5; the disease is type 2 diabetes mellitus.